Dec 29 (Reuters) - Avita Medical Ltd AVH.AX :
* AVITA MEDICAL RECEIVES U.S. FDA INVESTIGATIONAL DEVICE EXEMPTION APPROVAL OF CLINICAL FEASIBILITY STUDY TO EVALUATE RECELL SYSTEM FOR VITILIGO
* FDA'S DECISION ALLOWS CO TO BEGIN VITILIGO STUDY IN THE FIRST HALF OF 2020